Aspira Health Puerto Rico

Advancing Research in Puerto Rico

     Aspira Health Puerto Rico is set to have a profound impact on the health and well-being of Puerto Ricans by offering access to advanced clinical research in areas such as Wound Care, Cardiology, Oncology, Gastroenterology, Nephrology, and Neurology. This access will bring pioneering treatments and therapies to communities that may not otherwise have the opportunity to participate in cutting-edge research. Through high-quality, world-class studies, Aspira Health will help address pressing health issues, improve patient outcomes, and elevate Puerto Rico’s standing in global medical research.

​

    Each clinical area we focus on tackles vital health concerns. For example, Wound Care studies are crucial for managing chronic wounds, often affecting diabetic patients, and can prevent severe complications. Cardiology trials aim to address heart disease, a leading cause of mortality, while Oncology research strives to find advanced cancer treatments that could offer new hope to cancer patients. Gastroenterology, Nephrology, and Neurology studies aim to improve outcomes for those with digestive disorders, kidney diseases, and neurological conditions, respectively, enhancing quality of life for individuals facing these complex health challenges.

​

     Clinical trials are conducted in phases, each essential to ensuring treatment efficacy and safety. In Phase 1, trials assess a drug’s safety in a small group of healthy participants or patients. Phase 2 explores effectiveness and optimal dosing, Phase 3 expands to larger patient populations to confirm effectiveness and monitor side effects, and Phase 4 examines long-term effects post-approval. Aspira Health is one of the few organizations in Puerto Rico equipped to manage Phase 1 studies, which are foundational to the development of new treatments, made possible through our strategic partnership with Metro Pavia Health Systems.

​

     Bringing two decades of U.S.-based research experience to Puerto Rico, Aspira Health’s entry into the island’s healthcare landscape means more than just medical advancements—it represents an opportunity for local investment, job creation, and an enhanced healthcare ecosystem. By combining our expertise with the trusted reputation and reach of Metro Pavia Health Systems, we are set to transform Puerto Rico into a beacon for clinical research in the Caribbean, providing unprecedented health benefits to Puerto Ricans and showcasing the island’s potential to global investors.